Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OGFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PCDHA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CD274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLT3LG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFYVE26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSDMD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on